Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
COVID-19
Understanding FDA Regulatory Terminology During COVID-19
To update clinicians on the various terminology used by the FDA on treatments related to COVID-19 we have developed this reference…
The Impact COVID-19 is Having on ACOs
Recently, the National Association of Accountable Care Organizations (NAACOS) surveyed the Accountable Care Organization (ACO)…
CMS Issues Guidances and Suspends Rules to Battle COVID-19
In early April 2020, the Centers for Medicare and Medicaid Services (CMS) acted at the direction of President Donald Trump and…
FDA Eases Some Requirements in the COVID-19 Fight
Recently, the United States Food and Drug Administration (FDA) eased some requirements to allow for more access to masks, personal…
DEA Allows Controlled Substance Prescriptions to Be Issued Via Telemedicine
Recently, the United States Drug Enforcement Administration (DEA) updated its website FAQ to include notice that prescribers are…
Sanofi Doesn’t Expect Drug Shortages Related to COVID-19
One of the concerns patients have surrounding COVID-19 is the possibility of drug shortages, especially as countries around the…
DOJ, FDA and HHS Sound the Alarm About COVID-19 Fraud Schemes
Apparently, scammers are hard at work trying to exploit the COVID-19 pandemic. In the last couple of weeks, multiple agencies…
HHS Allows Pharmacists to Order and Administer COVID-19 Tests
On Wednesday, April 8, 2020, the United States Department of Health and Human Services (HHS) issued new guidance under the Public…
COVID-19 HHS and FCC Telehealth Changes
With COVID-19 raging throughout the country with restrictions on face to face interactions and encouragement of social distancing,…
Does Pharma Hold the Key to a COVID-19 Solution?
A frequent refrain we hear on the news these days is whether there are medicines and other potential solutions to help Americans…